Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 321

1.

Topical anti-itch therapy.

Hercogová J.

Dermatol Ther. 2005 Jul-Aug;18(4):341-3. Review.

PMID:
16297007
2.

Anti pruritic effects of topical crotamiton, capsaicin, and a corticosteroid on pruritogen-induced scratching behavior.

Sekine R, Satoh T, Takaoka A, Saeki K, Yokozeki H.

Exp Dermatol. 2012 Mar;21(3):201-4. doi: 10.1111/j.1600-0625.2011.01433.x.

PMID:
22379965
3.

Contact irritant dermatitis and anti-pruritic agents: the need to address the itch.

Burkhart CG, Burkhart HR.

J Drugs Dermatol. 2003 Apr;2(2):143-6. Review.

PMID:
12852365
4.

Treating pruritus. What's new in safe relief of symptoms?

Millikan LE.

Postgrad Med. 1996 Jan;99(1):173-6, 179-84. Review.

PMID:
8539203
5.

New treatment strategy and assessment questionnaire for external auditory canal pruritus: topical pimecrolimus therapy and Modified Itch Severity Scale.

Acar B, Karabulut H, Sahin Y, Babademez MA, Karadag AS, Karasen RM.

J Laryngol Otol. 2010 Feb;124(2):147-51. doi: 10.1017/S0022215109991459. Epub 2009 Nov 19.

PMID:
19922703
6.

Pruritus: an overview of current concepts.

Metz M, Grundmann S, Ständer S.

Vet Dermatol. 2011 Apr;22(2):121-31. doi: 10.1111/j.1365-3164.2010.00945.x. Epub 2011 Jan 20. Review.

PMID:
21251097
7.

Pruritus measurement and treatment.

Langner MD, Maibach HI.

Clin Exp Dermatol. 2009 Apr;34(3):285-8. doi: 10.1111/j.1365-2230.2009.03218.x. Review.

PMID:
19309370
8.

Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation.

Smith KJ, Skelton HG, Yeager J, Lee RB, Wagner KF.

Dermatology. 1997;195(4):353-8.

PMID:
9529556
9.
10.

The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis.

Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL.

Br J Dermatol. 2000 Nov;143(5):969-73.

PMID:
11069504
11.

What to do about pruritus scroti.

Kantor GR.

Postgrad Med. 1990 Nov 1;88(6):95-6, 99-102.

PMID:
2235790
12.

Successful treatment of genital pruritus using topical immunomodulators as a single therapy in multi-morbid patients.

Weisshaar E.

Acta Derm Venereol. 2008;88(2):195-6. doi: 10.2340/00015555-0410. No abstract available.

13.

A model to assess the effectiveness of topical antipruritics.

Drozdenko R, Pennisi SC, Minkin W, Spivak H, Weinstein S, Weinstein C.

Skin Pharmacol. 1996;9(5):334-42.

PMID:
8990509
14.

Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin.

Ständer S, Ständer H, Seeliger S, Luger TA, Steinhoff M.

Br J Dermatol. 2007 May;156(5):1020-6. Epub 2007 Mar 28.

PMID:
17388925
15.

Chronic pruritus: targets, mechanisms and future therapies.

Pogatzki-Zahn E, Marziniak M, Schneider G, Luger TA, Ständer S.

Drug News Perspect. 2008 Dec;21(10):541-51. doi: 10.1358/dnp.2008.21.10.1314057. Review.

PMID:
19221635
16.

[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].

Sukarovska BG, Lipozencić J, Vrzogić P.

Acta Med Croatica. 2007 Sep;61(4):375-81. Review. Croatian.

PMID:
18044472
17.

Effects of topical application of tacrolimus on acute itch-associated responses in mice.

Nakano T, Andoh T, Tayama M, Kosaka M, Lee JB, Kuraishi Y.

Biol Pharm Bull. 2008 Apr;31(4):752-4.

18.

Naltrexone for the management of post-burn pruritus: A preliminary report.

LaSalle L, Rachelska G, Nedelec B.

Burns. 2008 Sep;34(6):797-802. doi: 10.1016/j.burns.2007.10.009. Epub 2008 Mar 5.

PMID:
18325676
19.

Neurologic Itch Management.

Şavk E.

Curr Probl Dermatol. 2016;50:116-23. doi: 10.1159/000446053. Epub 2016 Aug 23. Review.

PMID:
27578080
20.

Double-blind, randomized, pilot study assessing the resolution of postburn pruritus.

Nedelec B, Rachelska G, Parnell LK, LaSalle L.

J Burn Care Res. 2012 May-Jun;33(3):398-406. doi: 10.1097/BCR.0b013e318233592e.

PMID:
21979845

Supplemental Content

Support Center